cbdMD (YCBD) Asset Writedowns and Impairment (2017 - 2023)

cbdMD (YCBD) has 7 years of Asset Writedowns and Impairment data on file, last reported at $175499.0 in Q3 2023.

• For the quarter ending Q3 2023, Asset Writedowns and Impairment rose 100.37% year-over-year to $175499.0; the trailing twelve-month figure through Dec 2023 stood at $175499.0 (up 101.01% YoY), and the FY2025 full-year result was $365979.0, down 60.28% from the prior year.
• Asset Writedowns and Impairment climbed to $175499.0 in Q3 2023, from -$48.1 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $30.8 million in Q2 2022 to a low of -$48.1 million in Q3 2022.
• A 5-year average of $34419.7 and a median of $118210.0 in 2020 frame the typical range for Asset Writedowns and Impairment.
• Across the five-year window, Asset Writedowns and Impairment soared 114.31% in 2020 and plunged 7270.15% in 2022, its largest moves.
• Tracing YCBD's Asset Writedowns and Impairment over 5 years: stood at $62011.0 in 2019, then soared by 90.63% to $118210.0 in 2020, then soared by 15282.19% to $18.2 million in 2021, then slumped by 364.43% to -$48.1 million in 2022, then jumped by 100.37% to $175499.0 in 2023.
• Business Quant data shows YCBD's Asset Writedowns and Impairment at $175499.0 in Q3 2023, -$48.1 million in Q3 2022, and $30.8 million in Q2 2022.